Association of Fatty Acid Signatures with HIV Viremia in Pregnancy.
HIV
antiretroviral therapy
fatty acids
omega-3
omega-6
pregnancy
Journal
AIDS research and human retroviruses
ISSN: 1931-8405
Titre abrégé: AIDS Res Hum Retroviruses
Pays: United States
ID NLM: 8709376
Informations de publication
Date de publication:
30 Oct 2023
30 Oct 2023
Historique:
pubmed:
29
9
2023
medline:
29
9
2023
entrez:
29
9
2023
Statut:
aheadofprint
Résumé
Omega-6 (n-6) and omega-3 (n-3) polyunsaturated fatty acids (PUFAs) are vital for fetal metabolic programming and immunomodulation. Higher n-6:n-3 ratios, reflecting a proinflammatory eicosanoid profile, are associated with adverse perinatal outcomes. Limited data exist, however, on n-6 and n-3 PUFAs specifically in the context of HIV and pregnancy. Our objective was to assess HIV clinical factors associated with PUFA signatures in pregnant persons with HIV (PWH). In this observational cohort, third trimester plasma PUFA concentrations (six n-6 PUFAs, four n-3 PUFAs) were measured, each as a percent of total fatty acid content, via esterification and gas chromatography in pregnant PWH enrolled from 2009 to 2011 in the Nutrition substudy of the Pediatric HIV/AIDS Cohort Study. PUFA ratios (n-6:n-3) were calculated. Exposures assessed were first/second trimester CD4 count (<200 vs.
Identifiants
pubmed: 37772708
doi: 10.1089/AID.2023.0040
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM